Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes-Reference-Cited by-同舟云学术

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes

Published:2015-07-21 Issue:3 Volume:314 Page:265
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Lewis James D.¹,Habel Laurel A.²,Quesenberry Charles P.²,Strom Brian L.³,Peng Tiffany²,Hedderson Monique M.²,Ehrlich Samantha F.²,Mamtani Ronac¹,Bilker Warren⁴,Vaughn David J.⁵,Nessel Lisa⁶,Van Den Eeden Stephen K.²,Ferrara Assiamira²

Affiliation:

1. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia2Department of Biostatistics and Epidemiology, University of Pennsylvania3Department of Medicine, University of Pennsylvania

2. Division of Research, Kaiser Permanente Northern California, Oakland

3. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia2Department of Biostatistics and Epidemiology, University of Pennsylvania5Rutgers Biomedical and Health Sciences, New Brunswick, New Jersey

4. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia2Department of Biostatistics and Epidemiology, University of Pennsylvania

5. Department of Medicine, University of Pennsylvania

6. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal relationship between type 2 diabetes and common respiratory system diseases: a two-sample Mendelian randomization analysis;Frontiers in Medicine;2024-07-18

2. A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes – 2nd edition (English version);Journal of Diabetes Investigation;2024-07-11

3. Associations between Diabetes Mellitus and Selected Cancers;International Journal of Molecular Sciences;2024-07-08

4. A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd Edition (English version);Diabetology International;2024-07

5. Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database;Diabetes, Obesity and Metabolism;2024-04